Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on BLUE CAPITAL REINSURANCE HOL. We currently have 2 research reports from 1 professional analysts.
Frequency of research reports
Research reports on
BLUE CAPITAL REINSURANCE HOL
BLUE CAPITAL REINSURANCE HOL
Debt & renewables dominate
09 Jan 14
A total of £3.1bn was raised in the funds sector in the fourth quarter of 2013, exceeding total funds raised for the whole of 2012 (£2.7bn). The alternative asset and income theme continued to dominate, with most successful vehicles offering yields in excess of 5%.
Summary of fund raising in the sector
03 Oct 13
Three successful fund raises were announced this morning, two IPOs and one placing: - DP Aircraft I (Dr Peters) – IPO at £c70m with Canaccord (oversubscribed). - Chenavari Capital Solutions Fund (Asset Backed Securities) – IPO at c£130m with Dexion (50% of the target). - John Laing Infrastructure (JLIF) – £243m under a placing (the maximum) with JPM Cazenove. Next to announce are the two C-Shares from ABAA (Monday) and BRNA (Thursday). Updated Q4 fund raising table follows, almost at £3bn now at the top end of the targets.
Another positive verdict
20 Mar 17
Burford’s results for 2016 produced another outstanding set of figures. Revenue grew by 60% to $163.4m with strong growth in the litigation finance business and an additional boost from a secondary sale in the Petersen case. On an underlying basis net income grew to $114m, a 75% increase despite the investment in growing capacity which increased costs. A combination of ongoing investment and gains and increases on valuation saw the fair value of the litigation assets increase 67% to $559m, underpinned by a growth in invested capital to $394m. With the results statement there was an announcement of a further sale of 9% of the Petersen case at a valuation of 20 times the cost of investment.
N+1 Singer - Morning Song 22-03-2017
22 Mar 17
Carador Income Fund (CIFU LN) Premium rating restored, high levels of refinancing activity | Cello Group (CLL LN) Outlook getting brighter – watch Pulsar | Eckoh (ECK LN) Largest ever US secure payments win | eg solutions (EGS LN) Full year results in line | Futura Medical (FUM LN) Licensing deal for CSD500 in Portugal | Verona Pharma (VRP LN) Global agreement with QuintilesIMS to support development of RPL554 | Xaar (XAR LN) 2016 results slightly ahead, reduced visibility in 2017
Small Cap Breakfast
21 Mar 17
First Sentinel—Investment company expecting NEX admission/introduction on 24 March. £636k raised pre-IPO. BioPharma Credit—Expected Gross Initial Acquisition Proceeds now c.$338m. Gross Cash Proceeds capped at $423m with placing and open offer. Results expected 23 March with admission now due 30 march. Tufton Oceanic Assets- The Company intends to invest in a diversified portfolio of second hand commercial sea-going vessels where the Investment Manager believes that an attractive opportunity exists in shipping. $150m raise. Admission 3 April.